Poct/Blood Diagnostics/Hba1c /HCG/Tsh/Pct/Crp/Ctni Immunoassay Analyzer

• Customized: Non-Customized
• Structure: Portable
• Material: Plastic
• Certification: CE, ISO
• Application: Hospital
• Type: Measurement Type
• Model NO.: GR200
• Transport Package: Carton
• Specification: 40X37X26CM
• Trademark: darppon
• Origin: China
• Production Capacity: 1000 Sets/Month

Product Description

Application

This POCT Immunoassay Quantitative Analyzer supports the reagents like Cardiac Markers, Inflammatory Markers,        Inflammatory Markers and Thrombus


 

Advantages

·High standards: quantitative detection, multiple quality control, with the accurate and stable results 

·High intelligence: automatic identification, full-automated detection with one 

button, Effective docking hospital lis system and automatic uploading data 

·High efficiency: real-time detection, automatic detection within 20 minutes, realizing fast batch testing 

·High flexible: a variety of supplementary reagents, covering heart, inflammation, kidney and other fields 

Supporting reagents and clinical application: 

·Cardiac markers 
Cardiac Troponin I / Myoglobin / Creatine Kinase Isoenzyme MB(cTnI/Myo/CK-MB) 

Clinical application: 

Early diagnosis of acute coronary syndrome; 

The prognosis and risk stratification of acute coronary syndrome evaluation; 

The forecast of myocardial infarction area; 

The indicator of thrombolysis and interventional therapy after acute myocardial infarction; 

Differential diagnosis of chest pain reasons; 

The evaluation of clinical therapeutic effect. 

Application department: cardiology department (outpatient clinic, and ward and CCU); emergency department (120 ambulance, ICU); Clinical laboratory, etc. 

Triad detection, including cTnI, Myo and CK-MB, can effectively avoid missed diagnosis and misdiagnosis. 

Heart-type fatty acid binding-protein (H-FABP) 

Clinical application: 

The earliest sensitive parameter of AMI diagnosis; 

The forecast of myocardial infarction area; 

The diagnosis and monitoring of traumatic myocardial injury; 

Recent predict cardiovascular events after coronary stent.

Early detection of H-FABP and Myo, and convalescent of cTnI and CK-MB, is helpful to select high-risk patients with myocardial damage. 


 

N-terminal pro-brain B-type natriuretic peptides(NT-proBNP) 

Clinical application: 

Prevention and detection of heart failure; 

Monitoring and evaluation of heart failure therapy; 

Diagnosis and risk stratification of heart failure; 

Risk stratification of acute coronary syndrome (ACS); 

Identification of heart failure and other reasons caused by breathing difficulties. 

Application department: cardiology department (outpatient clinic, and ward and CCU); emergency department (120 ambulance, ICU); pneumology Department, thoracic surgery, etc. 

·Inflammatory Markers 
  Procalcitonin(PCT) 
Clinical application: The identification of bacterial and viral infections; 

Identification and diagnosis of sepsis, assessment of the severity of the sepsis and disease progression, and prognosis of sepsis judgment; 

Accurate guidance for the use of antibiotic, avoiding the abuse of antibiotics; 

The differential diagnosis of fever infection after the surgery, radiotherapy and chemotherapy. 

Application department: infections department, pediatrics, respiratory infection, emergency department, cardiology, oncology, surgical department, etc. 

 

The use of PCT in the sepsis (ICU): 

PCT< 0.5ng/ml Showing that sepsis is extremely unlikely; 

PCT> 2 ng/ml Indicating that sepsis could escalate to septic shock. 

1)PCT guiding the use of antibiotics 

PCT< 0.1ng/ml Basic without the possibility of bacterial infection, not strongly 

recommend the use of antibiotics; 

PCT:0.1-0.25ng/ml Bacterial infection is unlikely, whether to use antibiotics 

should combined with clinical symptoms; 

PCT:0.25-0.5ng/ml There may be a need to treat bacterial infections and recommend the use of antibiotics; 

PCT> 0.5 ng/ml No doubt in need of treatment of bacterial infections, strongly recommend the use of antibiotic. 

 

C-reactive protein(hs-CRP+CRP) 

Clinical application: 

The identification of bacterial and viral infections; 

Effect evaluation of antibiotic treatment; 

The detection and postoperative monitoring in inflammatory disease; 

The risk of cardiovascular disease and treatment evaluation. 

Application department: Clinical laboratory, infections department, pediatrics, pneumology department, emergency department, cardiology department, surgical department, etc. 

Severity judgment of conventional inflammation 

CRP>50 ug/ml Serious bacterial infection; 

CRP:20-50 ug/ml General bacterial infections; 

CRP:10-20 ug/ml Viral or bacterial infection. 

1)Cardiovascular severe judgment 

hs CRP<1 ug/ml Low sick; 

hs CRP :1-3 ug/ml Moderate risk; 

hs CRP>3 ug/ml Highly dangerous. 

Thrombus 
 D-Dimer 

Clinical application: 

Exclusion and auxiliary diagnosis of deep venous thrombosis(DVT)and pulmonary embolism(PE); 

Diagnosis of disseminated intravascular coagulation(DIC); 

Surgery and thrombolytic therapy monitoring; 

Diagnosis and detection of high coagulation state of pregnancy-induced hypertension syndrome; 

Auxiliary diagnosis and prognosis of cerebral infarction. 

Application department: cardiology department, emergency department, pneumology department, neurology department, surgical department, etc. 

1)Suspected deep vein thrombosis(DVT)in clinic 

D-Dimer<0.5 ng/mL,Eliminating DVT; 

D-Dimer>0.5 ng/mL,Perfoming ultrasonic inspection, if positive, then must be treated with DVT, if negative, considering other clinical possibilities. 

2)Suspected pulmonary embolism(PE)in clinic 

D-Dimer<0.5 ng/mL,Eliminating PE; 

D-Dimer>0.5 ng/mL,Perfoming ultrasonic inspection, if positive, then must be treated with PE, if negative, make a definite diagnosis with ventilation/perfusion scans .